Day: July 21, 2025

Oslo, 21 July 2025 – DNO ASA, the Norwegian oil and gas operator, today confirmed a gas and condensate discovery on the Vidsyn prospect close to its producing Fenja oil and gas field, both within the Norwegian Sea license PL586. The Company has a 25 percent stake in the license, up from 7.5 percent prior to the recent acquisition of Sval Energi Group AS last month. Preliminary estimates put gross recoverable resources in the range of 25 to 40 million barrels of oil equivalent (MMboe) with a mean of 31 MMboe, above the pre-drill estimate range. The Vidsyn discovery was made in Middle Jurassic high-quality reservoir sandstones of the Ile formation. The partnership, including Vår Energi ASA (75 percent and operator), considers the discovery commercial and sees a potential to unlock a larger volume in the licence. “Vidsyn is another exciting...

IDEX is executing well on the strategy announced in March 2025 and outlined in the Company’s presentation held on 21 May 2025- IDEX-presentation-20250521.pdf. The Company’s strategy is to become the world’s leading biometric ID company, with a world class product portfolio in both ID & Access and Pay. IDEX has set out clear priorities, a disciplined capital allocation, and a sharp focus on building long-term value.   IDEX has delivered multiple test cards as part of signing letters of intent with customers and partners; the purpose of which being to enter into distribution and purchase agreements subject to successful trials of these test cards. Testing is currently taking place. The Company believes that these sample cards will demonstrate the advantages that IDEX technology has over competitors in the field. The feedback to date...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Oslo, Norway, 21 July 2025 IDEX Biometrics ASA (“IDEX” or the “Company”) has engaged Arctic Securities AS (the “Manager”) to advise on and effect a contemplated private placement in the Company of 9,090,909 new shares in the Company (the “Offer Shares”) raising gross proceeds of NOK 30 million (the “Private Placement”). The subscription price per Offer Share (the “Offer Price”) is NOK 3.30 per Offer Share. Altea AS, Pinchcliffe AS (closely associated...

The pivotal phase IIb ALIENTO study met the primary endpoint of a statistically significant reduction in the annualised exacerbation rate (AER) at 52 weeks when astegolimab was given every two weeks The phase III ARNASA study did not meet the primary endpoint of a statistically significant reduction in the AER at 52 weeks The safety profile of astegolimab was consistent with previously reported data, with no new safety signals identified Analysis of the ALIENTO and ARNASA data will be discussed with regulatory authorities and shared at an upcoming medical meetingBasel, 21 July 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today topline results from the pivotal phase IIb ALIENTO (n=1,301) and the phase III ARNASA (n=1,375) trials investigating astegolimab compared to placebo, on top of standard of care maintenance therapy...

WISeKey and SEALSQ Confirm New Cross-Border Center of Excellence for the 4th Industrial Revolution Activated Between La Line and GibraltarGibraltar/La Línea – July 21, 2025 – WISeKey International Holding Ltd (“WISeKey” or “Company”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, and its subsidiary, SEALSQ Corp (NASDAQ: LAES) (“SEALSQ”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products today announced that a transformative initiative launched several years ago to establish LLG4IRir.com a Cross-Border Deeptech Center of Excellence (the “Center”) for the 4th Industrial Revolution is now being formally activated, following the historic agreement between Spain and the United Kingdom on Gibraltar’s post-Brexit...

Geneva, Switzerland, July 21, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, and its parent company WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), today announced that a transformative initiative launched several years ago to establish LLG4IRir.com a Cross-Border Deeptech Center of Excellence (the “Center”) for the 4th Industrial Revolution is now being formally activated, following the historic agreement between Spain and the United Kingdom on Gibraltar’s post-Brexit border status. Strategically located near Gibraltar Airport, this innovative Center will act as a shared technological and industrial hub bridging La Línea...

Oslo, 21st of July – IDEX Biometrics ASA (OSE: IDEX) hereby announces a change to the company’s financial calendar. Postponement of Q2 2025 Report The company informs that the publication of the quarterly report for the second quarter of 2025 is postponed from the originally scheduled date to Tuesday, August 27, 2025. IDEX Biometrics’ reports and presentations are available on our website: www.idexbiometrics.com/investors For further information, please contact: Anders Storbråten, CEO and CFO, Tel: +47 416 38 582 E-mail: ir@idexbiometrics.com About IDEX Biometrics: IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences...

BEIJING, July 21, 2025 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a leader in Internet healthcare solutions, signed a Memorandum of Understanding with Novo Nordisk, a leading global healthcare company, at the 3rd China International Supply Chain Expo in Beijing. Leveraging its AI application services, innovative treatment solutions, and convenient pharmaceutical services, Fangzhou will collaborate with Novo Nordisk on managing serious chronic diseases, such as diabetes and obesity.Fangzhou and Novo Nordisk Signed Collaboration Memorandum Fangzhou’s founder, chairman, and CEO Dr. Xie Fangmin, and Christine Zhou, Novo Nordisk Senior Vice President & President of Region China, attended the signing ceremony. By leveraging Novo Nordisk’s expertise and innovative products...